The clinical features of 61 patients with sclerosing cholangitis were reviewed. This group included 23 patients with biliary tract calculi, commonly considered as excluding the diagnosis of primary scierosing cholangitis. The aim of this study was to compare these 23 patients (group A) with 38 patients with sclerosing cholangitis free of calculi (group B). Both groups had the following features in common: (i) age at presentation, (ii) incidence of inflammatory bowel disease, (iii) extent of radiological disease, (iv) prevalence of HLA-B8 and DR3 haplotype, (v) 
Primary sclerosing cholangitis is a chronic inflammatory disorder which results in fibrosis and obliteration of the intrahepatic and/or extrahepatic bile ducts leading to the typical radiological appearance of stricturing and beading of the biliary tree. The 19 (16%) in group B. All patients in group A were symptomatic at initial presentation (11 patients had right upper quadrant pain, eight had cholangitis, two had pruritus, and two had symptoms related to hepatic decompensation). This was the case whether or not calculi were present at the time. In contrast, only 23 of the 38 patients in group B (61 %) had clinical manifestations of their disease (cholangitis in eight patients, right upper quadrant pain in six patients, pruritus in three patients, and evidence of hepatic decompensation in six patients; p=0 0002). The remainder were asymptomatic and were being investigated for abnormal liver function tests.
The radiological extent of bile duct disease was similar in the two groups (Table II) . Of the patients in group A, the biliary calculi were present in the intrahepatic ducts in six patients, in both intrahepatic and extrahepatic ducts in a further six and in the extrahepatic ducts alone in 11 patients. In only three patients were single stones found. The remaining 20 had multiple biliary calculi of varying size. Thirteen patients in group A (57%) and seven in group B (18%) had associated cholecystolithiasis, diagnosed either before or at the time of diagnosis of sclerosing cholangitis (p=0002). This excess was largely accounted for by women (10/13 in group A v two of seven in group B).
Twelve patients (52%) in group A had recurrent episodes of ascending cholangitis during follow up compared with two patients in group B (5%). This difference was highly significant (p= 000005).
Nineteen patients in group A underwent various therapeutic manoeuvres in an attempt to clear the biliary tree of calculi. Endoscopic sphincterotomy was performed in 16 patients with successful removal of all calculi in seven. In a further five, percutaneous removal of residual intrahepatic stones was possible. Five of these 12 patients had endoscopic insertion of a biliary stent. A further five underwent percutaneous stent insertion in order to achieve biliary decompression. Despite these measures, biliary tract calculi recurred in all 12 patients after removal.
Nine patients in group A (39%) and eight patients in group B (21%) underwent hepatic transplantation because of progressive disease (p=0 07; NS). Uncontrollable intrahepatic sepsis, the result of recurrent calculi, complicated the course of three patients in group A, and was the indication for hepatic transplantation. Cholangiocarcinoma occurred in three patients in group A (13%) and five patients in group B (13%).
Six deaths occurred in group A (26%) and 10 in group B (26%) during the follow up period. Three patients in group A died after liver transplantation (one week to 19 months post transplant), two died from postoperative complications after cholecystectomy and one from massive hepatic necrosis of unknown cause. In group B, four patients died as a result of complications after hepatic transplantation (one week to 18 months post transplantation), four others 
